The Koo-Menter Psoriasis Instrument for Identifying Candidate Patients for Systemic Therapy

Abstract

Get full access to this article

View all access options for this article.

References

Krueger

, Koo

, Lebwohl

. The impact of psoriasis on quality of life. Results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol 2001; 137: 280–284.

Krueger

G.G.

, Feldman

S.R.

, Camisa

. Two considerations for patients with psoriasis and their clinicians: What defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis? J Am Acad Dermatol 2000; 43: 281–285.

Koo

Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment.

Psychodermatotogy 1996; 14: 485–496.

Koo

, Kozma

C.M.

, Reinke

The development of a disease-specific questionnaire to assess the quality of life for psoriasis patients: an analysis of the reliability, validity, and responsiveness of the psoriasis quality of life questionnaire.

Dermatologie + Psychosomatik 2002; 3: 171–179.

Koo

, Kozma

C.M.

, Menter

. Development of a disease specific quality of life questionnaire: the 12-item psoriasis quality of life questionnaire (PQOL-12). Poster presented at the American Academy of Dermatology, 61st Annual Meeting, March 21–26, 2003, San Francisco, California.